142 related articles for article (PubMed ID: 2896364)
1. Effect of mifentidine on mepirizole-induced duodenal ulcer in the rat.
Brambilla A; Ghiorzi A; De Paoli AM; Giachetti A
Pharmacol Res Commun; 1987 Dec; 19(12):877-85. PubMed ID: 2896364
[TBL] [Abstract][Full Text] [Related]
2. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
[TBL] [Abstract][Full Text] [Related]
3. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
Scarpignato C; Tramacere R; Zappia L
Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
5. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
6. Effects of antiulcer agents on healing of mepirizole-induced duodenal ulcers in rats.
Ishihara Y; Okabe S
Digestion; 1983; 27(1):29-35. PubMed ID: 6136443
[TBL] [Abstract][Full Text] [Related]
7. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
[TBL] [Abstract][Full Text] [Related]
8. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
9. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
Poli E; Medici D; Contini GA; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
[TBL] [Abstract][Full Text] [Related]
10. Mepirizole-induced duodenal ulcers in rats and their pathogenesis.
Okabe S; Ishihara Y; Inoo H; Tanaka H
Dig Dis Sci; 1982 Mar; 27(3):242-9. PubMed ID: 6122549
[TBL] [Abstract][Full Text] [Related]
11. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists.
Reilly PE; Mason SR; Gillam EM
Xenobiotica; 1988 Apr; 18(4):381-7. PubMed ID: 2899931
[TBL] [Abstract][Full Text] [Related]
13. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
14. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
15. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog.
Pagani F; Zecca M; Giachetti A
Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):349-51. PubMed ID: 2891046
[TBL] [Abstract][Full Text] [Related]
18. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
19. Effect of H2-receptor blockade on gastric mucus composition. A comparative study with ranitidine and famotidine.
Guslandi M; Testoni PA; Masci E
J Int Med Res; 1987; 15(4):224-6. PubMed ID: 2888693
[TBL] [Abstract][Full Text] [Related]
20. Action of mifentidine and ranitidine on the isolated rat uterus.
Poli E; Coruzzi G; Bertaccini G
Pharmacol Res Commun; 1984 Nov; 16(11):1091-100. PubMed ID: 6151674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
